EnZeta Immunotherapies, Inc.
Biotechnology company · Coral Gables, Florida, United States
EnZeta Immunotherapies, Inc. is a biotechnology company headquartered in Coral Gables, Florida, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $840,000 sold in a notice filed in 2026.
EnZeta Immunotherapies at a glance
What does EnZeta Immunotherapies do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $840,000 sold (2026).
Frequently asked questions about EnZeta Immunotherapies
Where is EnZeta Immunotherapies headquartered?
EnZeta Immunotherapies, Inc. is headquartered in Coral Gables, Florida, United States.
What does EnZeta Immunotherapies do?
EnZeta Immunotherapies, Inc. is a biotechnology company.
When was EnZeta Immunotherapies founded?
The earliest incorporation on record for EnZeta Immunotherapies, Inc. is in 2023, according to public company registers.
Similar companies
- Heartpoint Global Inc.Coral Gables, Florida, United States
- Adze Biotechnology IncCoral Gables, Florida, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences